MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Superintelligence

MAIPI: A Novel AI-Powered Prognostic Index for Mantle Cell Lymphoma Using Routine Histology

MedXY Editorial Team•Jul 12, 2026•Superintelligence
artificial intelligencedeep learningHematoxylin and EosinMantle Cell LymphomaPrognostic index

Highlight

Mantle Cell Lymphoma (MCL) exhibits heterogeneous clinical outcomes, creating challenges in patient risk stratification and treatment selection. MAIPI (MCL Artificial Intelligence Prognostic Index) is an innovative deep learning algorithm trained exclusively on routine Hematoxylin and Eosin (H&E) stained biopsy images, enabling prognostic prediction without specialized molecular or immunohistochemical analyses. Validated in large independent cohorts, MAIPI independently predicts survival, outperforming or complementing established clinical indices such as MIPI and Ki67 proliferation index.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Deep Learning on CT Scans Enhances Prognostication of Interstitial Lung AbnormalitiesA deep learning model classifying usual interstitial pneumonia patterns on CT scans predicts fibrosis progression and mortality in individuals with interstitial lung abnormalities, offering a promising tool for risk stratification and cliniOct 20, 2026Evaluating Conversational AI in Urgent Primary Care: A Prospective Feasibility Study of the Articulate Medical Intelligence ExplorerThis study assesses the safety, quality, and user acceptance of a conversational AI system aiding urgent primary care by engaging patients before appointments, demonstrating promising feasibility for clinical integration.Oct 18, 2026Navigating the Landscape of FDA-Approved Surgical AI Devices: Innovation, Evidence, and Regulatory ChallengesThis article analyzes FDA-approved surgical AI devices, highlighting trends in technology, evidence quality, regulatory pathways, and implications for clinical adoption.Oct 16, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Harnessing Deep Learning for Accurate Differentiation of Fibro-Osseous Jaw Lesions
A novel deep learning model significantly improves diagnostic accuracy in distinguishing fibro-osseous jaw lesions (FD, COF, COD) from histology images, outperforming expert pathologists and offering a promising diagnostic support tool.
Oct 16, 2026
The Role of Medical Interpreters in Enhancing Resilience and the Challenges for Artificial Intelligence IntegrationThis review synthesizes evidence on medical interpreters’ critical roles in supporting resilience for non-English language preference patients during ambulatory diagnostic care, highlighting gaps and implications for AI interpretationOct 15, 2026
Refining Prognostication in Advanced Mycosis Fungoides and Sézary Syndrome: The Role of the Cutaneous Lymphoma International Prognostic Index (CLIPI)The Cutaneous Lymphoma International Prognostic Index (CLIPI) enhances risk stratification and predicts progression and treatment response beyond conventional staging in advanced mycosis fungoides and Sézary syndrome.Oct 14, 2026